Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 531

1.

Anti-Inflammatory Thioredoxin Family Proteins for Medicare, Healthcare and Aging Care.

Yodoi J, Matsuo Y, Tian H, Masutani H, Inamoto T.

Nutrients. 2017 Sep 29;9(10). pii: E1081. doi: 10.3390/nu9101081. Review.

2.

Thioredoxin-1 maintains mechanistic target of rapamycin (mTOR) function during oxidative stress in cardiomyocytes.

Oka SI, Hirata T, Suzuki W, Naito D, Chen Y, Chin A, Yaginuma H, Saito T, Nagarajan N, Zhai P, Bhat S, Schesing K, Shao D, Hirabayashi Y, Yodoi J, Sciarretta S, Sadoshima J.

J Biol Chem. 2017 Nov 17;292(46):18988-19000. doi: 10.1074/jbc.M117.807735. Epub 2017 Sep 22.

3.

Editorial: Inflammatory Signaling in Bone Marrow Failure and Hematopoietic Malignancy.

Trompouki E, Mullen L, Fernandez-Reyes D, Yodoi J, Kim S, Schuettpelz LG.

Front Immunol. 2017 Jun 2;8:660. doi: 10.3389/fimmu.2017.00660. eCollection 2017. No abstract available.

4.

Differential expression of thioredoxin binding protein-2/Txnip in human placenta: Possible involvement of hypoxia in its suppression during early pregnancy.

Mogami H, Yura S, Kondoh E, Masutani H, Yodoi J, Konishi I.

J Obstet Gynaecol Res. 2017 Jan;43(1):50-56. doi: 10.1111/jog.13149. Epub 2016 Oct 20.

PMID:
27762463
5.

Axonal protection by thioredoxin-1 with inhibition of interleukin-1β in TNF-induced optic nerve degeneration.

Kitaoka Y, Tanito M, Kojima K, Sase K, Kaidzu S, Munemasa Y, Takagi H, Ohira A, Yodoi J.

Exp Eye Res. 2016 Nov;152:71-76. doi: 10.1016/j.exer.2016.09.007. Epub 2016 Sep 21.

PMID:
27664905
6.

Human thioredoxin-1 attenuates the rate of lipopolysaccharide-induced preterm delivery in mice in association with its anti-inflammatory effect.

Namba F, Kobayashi-Miura M, Goda T, Nakura Y, Nishiumi F, Son A, Kubota A, Yodoi J, Yanagihara I.

Pediatr Res. 2016 Sep;80(3):433-9. doi: 10.1038/pr.2016.100. Epub 2016 Apr 21.

PMID:
27100048
7.

Thiol redox barrier; local and systemic surveillance against stress and inflammatory diseases.

Yodoi J, Tian H, Masutani H, Nakamura H.

Arch Biochem Biophys. 2016 Apr 1;595:88-93. doi: 10.1016/j.abb.2015.11.029.

PMID:
27095222
8.

Induction of thioredoxin-1 in response to oxidative stress in dogs.

Munakata S, Tanaka Y, Nezu Y, Harada Y, Yogo T, Hara Y, Tian H, Matsuo Y, Tagawa M, Yodoi J.

Am J Vet Res. 2015 Jun;76(6):554-60. doi: 10.2460/ajvr.76.6.554.

PMID:
26000603
9.

Renal redox dysregulation in AKI: application for oxidative stress marker of AKI.

Kasuno K, Shirakawa K, Yoshida H, Mori K, Kimura H, Takahashi N, Nobukawa Y, Shigemi K, Tanabe S, Yamada N, Koshiji T, Nogaki F, Kusano H, Ono T, Uno K, Nakamura H, Yodoi J, Muso E, Iwano M.

Am J Physiol Renal Physiol. 2014 Dec 15;307(12):F1342-51. doi: 10.1152/ajprenal.00381.2013. Epub 2014 Oct 1.

10.

Protective effects of oral administration of yeast thioredoxin against gastric mucosal injury.

Taketani Y, Kinugasa K, Kitajima R, Nishiumi S, Ashida H, Nakamura H, Fujita T, Kanzaki K, Masutani H, Yodoi J.

Biosci Biotechnol Biochem. 2014;78(7):1221-30. doi: 10.1080/09168451.2014.915733. Epub 2014 Jun 18.

PMID:
25229862
11.

Effect of selenite on T-cell mitogenesis: contribution of ROS production and apoptosis signal-regulating kinase 1.

Ueno H, Kajihara H, Nakamura H, Okuno T, Sakazaki F, Arakawa T, Ogino H, Nakamuro K, Yodoi J.

Biol Pharm Bull. 2014;37(8):1352-8.

12.

Nanoceria and thioredoxin regulate a common antioxidative gene network in tubby mice.

Cai X, Yodoi J, Seal S, McGinnis JF.

Adv Exp Med Biol. 2014;801:829-36. doi: 10.1007/978-1-4614-3209-8_104.

PMID:
24664777
13.

Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases.

Yoshihara E, Masaki S, Matsuo Y, Chen Z, Tian H, Yodoi J.

Front Immunol. 2014 Jan 9;4:514. doi: 10.3389/fimmu.2013.00514. Review.

14.

Nitrosative/oxidative stress conditions regulate thioredoxin-interacting protein (TXNIP) expression and thioredoxin-1 (TRX-1) nuclear localization.

Ogata FT, Batista WL, Sartori A, Gesteira TF, Masutani H, Arai RJ, Yodoi J, Stern A, Monteiro HP.

PLoS One. 2013 Dec 20;8(12):e84588. doi: 10.1371/journal.pone.0084588. eCollection 2013.

15.

Thioredoxin-1 protects against neutrophilic inflammation and emphysema progression in a mouse model of chronic obstructive pulmonary disease exacerbation.

Tanabe N, Hoshino Y, Marumo S, Kiyokawa H, Sato S, Kinose D, Uno K, Muro S, Hirai T, Yodoi J, Mishima M.

PLoS One. 2013 Nov 11;8(11):e79016. doi: 10.1371/journal.pone.0079016. eCollection 2013.

16.

Thioredoxin ameliorates cutaneous inflammation by regulating the epithelial production and release of pro-inflammatory cytokines.

Tian H, Matsuo Y, Fukunaga A, Ono R, Nishigori C, Yodoi J.

Front Immunol. 2013 Sep 9;4:269. doi: 10.3389/fimmu.2013.00269. eCollection 2013.

17.

Thioredoxin-1 attenuates early graft loss after intraportal islet transplantation in mice.

Asami K, Inagaki A, Imura T, Sekiguchi S, Fujimori K, Masutani H, Yodoi J, Satomi S, Ohuchi N, Goto M.

PLoS One. 2013 Aug 9;8(8):e70259. doi: 10.1371/journal.pone.0070259. eCollection 2013.

18.

Extracellular thioredoxin: a therapeutic tool to combat inflammation.

Matsuo Y, Yodoi J.

Cytokine Growth Factor Rev. 2013 Aug;24(4):345-53. doi: 10.1016/j.cytogfr.2013.01.001. Epub 2013 Feb 9. Review.

PMID:
23403036
19.

Suppressive effect of administration of recombinant human thioredoxin on cutaneous  inflammation caused by UV.

Ono R, Fukunaga A, Masaki T, Yu X, Yodoi J, Nishigori C.

Bioengineered. 2013 Jul-Aug;4(4):254-7. doi: 10.4161/bioe.23612. Epub 2013 Jan 17.

20.

Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study.

Kawanaka M, Nishino K, Nakamura J, Suehiro M, Goto D, Urata N, Oka T, Kawamoto H, Nakamura H, Yodoi J, Hino K, Yamada G.

Hepat Med. 2013 Mar 4;5:11-6. doi: 10.2147/HMER.S41258. eCollection 2013.

21.

Redox-active protein thioredoxin-1 administration ameliorates influenza A virus (H1N1)-induced acute lung injury in mice.

Yashiro M, Tsukahara H, Matsukawa A, Yamada M, Fujii Y, Nagaoka Y, Tsuge M, Yamashita N, Ito T, Yamada M, Masutani H, Yodoi J, Morishima T.

Crit Care Med. 2013 Jan;41(1):171-81. doi: 10.1097/CCM.0b013e3182676352.

22.

The expression of thioredoxin-1 in preterm delivery placenta.

Song J, Dong X, Chen Y, Chen G, Liang H, Nakamura H, Yodoi J, Bai J.

Redox Rep. 2012;17(5):187-93. doi: 10.1179/1351000212Y.0000000021.

PMID:
23068965
23.

The protective role of the transmembrane thioredoxin-related protein TMX in inflammatory liver injury.

Matsuo Y, Irie K, Kiyonari H, Okuyama H, Nakamura H, Son A, Lopez-Ramos DA, Tian H, Oka S, Okawa K, Kizaka-Kondoh S, Masutani H, Yodoi J.

Antioxid Redox Signal. 2013 Apr 10;18(11):1263-72. doi: 10.1089/ars.2011.4430. Epub 2012 Oct 25.

24.

Nuclear expression of thioredoxin-1 in the invasion front is associated with outcome in patients with gallbladder carcinoma.

Nagano M, Hatakeyama K, Kai M, Nakamura H, Yodoi J, Asada Y, Chijiiwa K.

HPB (Oxford). 2012 Sep;14(9):573-82. doi: 10.1111/j.1477-2574.2012.00482.x. Epub 2012 Jun 8.

25.

Overexpression of glutaredoxin protects cardiomyocytes against nitric oxide-induced apoptosis with suppressing the S-nitrosylation of proteins and nuclear translocation of GAPDH.

Inadomi C, Murata H, Ihara Y, Goto S, Urata Y, Yodoi J, Kondo T, Sumikawa K.

Biochem Biophys Res Commun. 2012 Aug 31;425(3):656-61. doi: 10.1016/j.bbrc.2012.07.118. Epub 2012 Jul 27.

PMID:
22846575
26.

Deficiency of thioredoxin binding protein-2 (TBP-2) enhances TGF-β signaling and promotes epithelial to mesenchymal transition.

Masaki S, Masutani H, Yoshihara E, Yodoi J.

PLoS One. 2012;7(6):e39900. doi: 10.1371/journal.pone.0039900. Epub 2012 Jun 29.

27.

Suppressive effect of recombinant human thioredoxin on ultraviolet light-induced inflammation and apoptosis in murine skin.

Ono R, Masaki T, Dien S, Yu X, Fukunaga A, Yodoi J, Nishigori C.

J Dermatol. 2012 Oct;39(10):843-51. doi: 10.1111/j.1346-8138.2012.01566.x. Epub 2012 May 9.

PMID:
22568890
28.

Attenuation of indomethacin-induced gastric mucosal injury by prophylactic administration of sake yeast-derived thioredoxin.

Nakajima A, Fukui T, Takahashi Y, Kishimoto M, Yamashina M, Nakayama S, Sakaguchi Y, Yoshida K, Uchida K, Nishio A, Yodoi J, Okazaki K.

J Gastroenterol. 2012 Sep;47(9):978-87. doi: 10.1007/s00535-012-0564-5. Epub 2012 Mar 9.

29.

Induction of endoplasmic reticulum stress and the modulation of thioredoxin-1 in formaldehyde-induced neurotoxicity.

Luo FC, Zhou J, Lv T, Qi L, Wang SD, Nakamura H, Yodoi J, Bai J.

Neurotoxicology. 2012 Jun;33(3):290-8. doi: 10.1016/j.neuro.2012.02.004. Epub 2012 Feb 10.

PMID:
22342837
30.

Geranylgeranylacetone protects mice against morphine-induced hyperlocomotion, rewarding effect, and withdrawal syndrome.

Luo FC, Qi L, Lv T, Wang SD, Liu H, Nakamura H, Yodoi J, Bai J.

Free Radic Biol Med. 2012 Apr 1;52(7):1218-27. doi: 10.1016/j.freeradbiomed.2012.01.004. Epub 2012 Jan 18.

PMID:
22285390
31.

Thioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus.

Masutani H, Yoshihara E, Masaki S, Chen Z, Yodoi J.

J Clin Biochem Nutr. 2012 Jan;50(1):23-34. doi: 10.3164/jcbn.11-36SR. Epub 2011 Oct 26.

32.

Discovery of ATL: an odyssey in restrospect.

Yodoi J, Maeda M.

Int J Hematol. 2011 Nov;94(5):423-8. doi: 10.1007/s12185-011-0957-x. Epub 2011 Nov 9. Review.

PMID:
22068231
33.

Yeast thioredoxin-enriched extracts for mitigating the allergenicity of foods.

Taketani Y, Kinugasa K, Furukawa S, Nakamura H, Otsuki R, Yasuda H, Fujita T, Kanzaki K, Masutani H, Yodoi J.

Biosci Biotechnol Biochem. 2011;75(10):1872-9. Epub 2011 Oct 7.

34.

Thioredoxin 1 overexpression extends mainly the earlier part of life span in mice.

Pérez VI, Cortez LA, Lew CM, Rodriguez M, Webb CR, Van Remmen H, Chaudhuri A, Qi W, Lee S, Bokov A, Fok W, Jones D, Richardson A, Yodoi J, Zhang Y, Tominaga K, Hubbard GB, Ikeno Y.

J Gerontol A Biol Sci Med Sci. 2011 Dec;66(12):1286-99. doi: 10.1093/gerona/glr125. Epub 2011 Aug 26.

35.

Thioredoxin-interacting protein suppresses bladder carcinogenesis.

Nishizawa K, Nishiyama H, Matsui Y, Kobayashi T, Saito R, Kotani H, Masutani H, Oishi S, Toda Y, Fujii N, Yodoi J, Ogawa O.

Carcinogenesis. 2011 Oct;32(10):1459-66. doi: 10.1093/carcin/bgr137. Epub 2011 Jul 18.

36.

Thioredoxin in allergic inflammation.

Ito W, Kobayashi N, Takeda M, Ueki S, Kayaba H, Nakamura H, Yodoi J, Chihara J.

Int Arch Allergy Immunol. 2011;155 Suppl 1:142-6. doi: 10.1159/000327501. Epub 2011 Jun 1. Review.

PMID:
21646810
37.

Production of biologically active human thioredoxin 1 protein in lettuce chloroplasts.

Lim S, Ashida H, Watanabe R, Inai K, Kim YS, Mukougawa K, Fukuda H, Tomizawa K, Ushiyama K, Asao H, Tamoi M, Masutani H, Shigeoka S, Yodoi J, Yokota A.

Plant Mol Biol. 2011 Jul;76(3-5):335-44. doi: 10.1007/s11103-011-9745-5. Epub 2011 Feb 3.

PMID:
21290168
38.

Thioredoxin-binding protein-2 (TBP-2/VDUP1/TXNIP) regulates T-cell sensitivity to glucocorticoid during HTLV-I-induced transformation.

Chen Z, Lopez-Ramos DA, Yoshihara E, Maeda Y, Masutani H, Sugie K, Maeda M, Yodoi J.

Leukemia. 2011 Mar;25(3):440-8. doi: 10.1038/leu.2010.286. Epub 2010 Dec 10.

39.

Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity.

Yoshihara E, Fujimoto S, Inagaki N, Okawa K, Masaki S, Yodoi J, Masutani H.

Nat Commun. 2010 Nov 23;1:127.

40.

Thioredoxin binding protein-2 mediates metabolic adaptation in response to lipopolysaccharide in vivo.

Oka S, Liu W, Yoshihara E, Ahsan MK, Ramos DA, Son A, Okuyama H, Zhang L, Masutani H, Nakamura H, Yodoi J.

Crit Care Med. 2010 Dec;38(12):2345-51. doi: 10.1097/CCM.0b013e3181f85b2a.

PMID:
20838331
41.

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, Mullooly N, Mielke LA, Harris J, Coll RC, Mills KH, Mok KH, Newsholme P, Nuñez G, Yodoi J, Kahn SE, Lavelle EC, O'Neill LA.

Nat Immunol. 2010 Oct;11(10):897-904. doi: 10.1038/ni.1935. Epub 2010 Sep 12.

42.

Thiol redox transitions by thioredoxin and thioredoxin-binding protein-2 in cell signaling.

Yoshihara E, Chen Z, Matsuo Y, Masutani H, Yodoi J.

Methods Enzymol. 2010;474:67-82. doi: 10.1016/S0076-6879(10)74005-2. Epub 2010 Jun 20.

PMID:
20609905
43.

Transgenic mice overproducing human thioredoxin-1, an antioxidative and anti-apoptotic protein, prevents diabetic embryopathy.

Kamimoto Y, Sugiyama T, Kihira T, Zhang L, Murabayashi N, Umekawa T, Nagao K, Ma N, Toyoda N, Yodoi J, Sagawa N.

Diabetologia. 2010 Sep;53(9):2046-55. doi: 10.1007/s00125-010-1784-y. Epub 2010 May 29.

PMID:
20512310
44.

Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2.

Watanabe R, Nakamura H, Masutani H, Yodoi J.

Pharmacol Ther. 2010 Sep;127(3):261-70. doi: 10.1016/j.pharmthera.2010.04.004. Epub 2010 May 8. Review. Erratum in: Pharmacol Ther. 2011 Feb;129(2):239.

PMID:
20435060
45.

DHEA attenuates PDGF-induced phenotypic proliferation of vascular smooth muscle A7r5 cells through redox regulation.

Urata Y, Goto S, Kawakatsu M, Yodoi J, Eto M, Akishita M, Kondo T.

Biochem Biophys Res Commun. 2010 May 28;396(2):489-94. doi: 10.1016/j.bbrc.2010.04.125. Epub 2010 Apr 24.

PMID:
20420805
46.

Differential roles of Annexin A1 (ANXA1/lipocortin-1/lipomodulin) and thioredoxin binding protein-2 (TBP-2/VDUP1/TXNIP) in glucocorticoid signaling of HTLV-I-transformed T cells.

Chen Z, Yoshihara E, Son A, Matsuo Y, Masutani H, Sugie K, Maeda M, Yodoi J.

Immunol Lett. 2010 Jun 15;131(1):11-8. doi: 10.1016/j.imlet.2010.04.003. Epub 2010 Apr 14.

PMID:
20398702
47.

Neuroprotective effect of overexpression of thioredoxin on photoreceptor degeneration in Tubby mice.

Kong L, Zhou X, Li F, Yodoi J, McGinnis J, Cao W.

Neurobiol Dis. 2010 Jun;38(3):446-55. doi: 10.1016/j.nbd.2010.03.005. Epub 2010 Mar 16.

48.

Thioredoxin suppresses airway inflammation independently of systemic Th1/Th2 immune modulation.

Torii M, Wang L, Ma N, Saito K, Hori T, Sato-Ueshima M, Koyama Y, Nishikawa H, Katayama N, Mizoguchi A, Shiku H, Yodoi J, Kuribayashi K, Kato T.

Eur J Immunol. 2010 Mar;40(3):787-96. doi: 10.1002/eji.200939724.

49.

Changes in thioredoxin concentrations: an observation in an ultra-marathon race.

Marumoto M, Suzuki S, Hosono A, Arakawa K, Shibata K, Fuku M, Goto C, Tokudome Y, Hoshino H, Imaeda N, Kobayashi M, Yodoi J, Tokudome S.

Environ Health Prev Med. 2010 May;15(3):129-34. doi: 10.1007/s12199-009-0119-4. Epub 2009 Dec 4.

50.

Panaxatriol saponins extracted from Panax notoginseng induces thioredoxin-1 and prevents 1-methyl-4-phenylpyridinium ion-induced neurotoxicity.

Luo FC, Wang SD, Li K, Nakamura H, Yodoi J, Bai J.

J Ethnopharmacol. 2010 Feb 3;127(2):419-23. doi: 10.1016/j.jep.2009.10.023. Epub 2009 Oct 24.

PMID:
19857566

Supplemental Content

Support Center